ISI NucMed 2022 – June 27-29th 2022, Nantes
Interdisciplinary School In Nuclear Medicine (ISI NucMed) 2022 Arronax organises the Interdisciplinary School (ISI) In Nuclear Medicine (NucMed) from 27
SIRIC ILIAD’s research on breast cancer in video
Video : Introduction to SIRIC ILIAD’s research work on breast cancer The SIRIC ILIAD Nantes-Angers (Integrated Cancer Research Site) was
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer : The OPALESCENCE study, a collaborative research
Nantes research on astatine in the spotlight
Nantes research on astatine in the spotlight Astatine (At) is the rarest chemical element on Earth, and its 211 isotope
The European Medical Radionuclides Programme – PRISMAP – Arronax
GIP ARRONAX is part of the European medical isotope programme PRISMAP, which aims to fundamentally change the European medical radionuclide
The Scientific Advisory Board (SAB) of SIRIC ILIAD met on 16 & 17 September 2021
The International Scientific Advisory Board (SAB) met on 16 & 17 September 2021: review and improvement perspectives The role of
